MicroSigX

MicroSigX is a spin-off from the Chinese University of Hong Kong, founded by a team of world-class clinical scientists. With our mission to "Improve Life Through Microbiome Diagnostics," we are focused on developing revolutionary non-invasive diagnostic solutions. We pioneered patented stool testing technology that accurately decodes the unique signatures of the human microbiome. This innovative technology provides rapid, accurate, and cost-effective early detection for a variety of major global diseases, including colorectal cancer (CRC), neurological conditions such as autism spectrum disorder and attention deficit hyperactivity disorder (ASD/ADHD), and inflammatory bowel disease (IBD). We are actively promoting Hong Kong as a global leader in the microbiome diagnostics industry, contributing to the health and well-being of all people.